Published: Guidance, quality standards and advice

Skip to filtersSkip to results

Skip to results

Keyword or reference number

Keyword or reference number

Last updated date

Last updated date

Area of interest

Area of interest

Type

Type

Guidance programme

Advice programme

Showing 1 to 10 of 1526

TitleReference numberPublishedLast updated
Digital technologies for assessing attention deficit hyperactivity disorder (ADHD)DG60
Belzutifan for treating tumours associated with von Hippel-Lindau diseaseTA1011
Acute kidney injury: prevention, detection and managementNG148
Latanoprost–netarsudil for previously treated primary open-angle glaucoma or ocular hypertensionTA1009
Trifluridine–tipiracil with bevacizumab for treating metastatic colorectal cancer after 2 systemic treatmentsTA1008
Burosumab for treating X-linked hypophosphataemia in children and young peopleHST8
Rucaparib for maintenance treatment of relapsed platinum-sensitive ovarian, fallopian tube or peritoneal cancerTA1007
Empagliflozin for treating type 2 diabetes in people 10 to 17 years (terminated appraisal)TA1006
Evinacumab for treating homozygous familial hypercholesterolaemia in people 12 years and overTA1002
Exagamglogene autotemcel for treating transfusion-dependent beta-thalassaemia in people 12 years and overTA1003

Results per page

  1. 10
  2. 25
  3. 50
  4. All